Episode Details
Back to Episodes
PODCAST | Efficient Communication Reduces Regulatory Uncertainty — CBER Director, US FDA
Published 2 years, 3 months ago
Description
Dr. Peter Marks, Director of the Center for Biologics Evaluation and Research (CBER), U.S. Food and Drug Administration (FDA), speaks with Chris Houchin, Partner at Guidehouse, in a video interview about leveraging AI at the agency, developments in data driven healthcare, and improving communication regarding frontier topics like explainability, data integrity, bias, and data security.